ZUPLYSO owner Contact Information online
from Pfizer Inc.
ZUPLYSO
US serial number:85138920
Application filling date:Sep. 27, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Dec. 03, 2012
Publication date:Mar. 08, 2011
Abandoned date:Dec. 03, 2012
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceuticals for use in the treatment of lysosomal storage diseases
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Class Status: ACTIVE
Basis: 1(b)
Services:Pharmaceuticals for use in the treatment of lysosomal storage diseases
Current owner owner name:Pfizer Inc.
Current owner owner address:235 East 42nd Street
New York,
NEW YORK
UNITED STATES
10017
Current owner legal entity type:CORPORATION
Current owner state or country:DELAWARE
Attorney name:Jane Ungaro
Attorney docket number:PHYLYSO
Correspondent name address:JANE UNGARO
PFIZER INC.
150 E 42ND ST
NEW YORK,
NEW YORK
UNITED STATES
10017-5612
Correspondent phone:212-733-5211
Correspondent fax:212-573-2273
Trademark staff tm attorney:MCBRIDE, THEODORE M
Trademark staff law office assigned ZUPLYSO:LAW OFFICE 103
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (131) JOHNSON & JOHNSON (125) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Pfizer Inc. (47) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Bristol-Myers Squibb Company (34) Forest Laboratories, Inc. (34) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Apr. 19, 2011 Mar. 29, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010 Apr. 05, 2011
